Background illustration for clinical trials search

Paid Clinical Trials Tacoma

Discover 1,438 paid clinical trials in Tacoma, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

SX-682 With Pembrolizumab for the Treatment of Metastatic or Recurrent Stage IIIC or IV Non-Small Cell Lung Cancer

for
Metastatic Lung Non-Small Cell Carcinoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT05570825

Phase2, Recruiting

HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

for
Fanconi Anemia, Severe Marrow Failure,
Location: Seattle WA, Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 0+

Code: NCT02143830

Phase2, Recruiting

A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)

for
Chronic Myeloid Leukemia, Chronic Phase,
Location: Seattle WA, Portland OR, Eugene OR, Salt Lake City UT,
Sponsor: Terns, Inc.

Sex: All

Age: 18+

Code: NCT06163430

Phase1, Phase2, Recruiting

Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies

for
Castrate Resistant Prostate Cancer, NUT Carcinoma,
Location: Seattle WA, Phoenix AZ, Rochester MN, Houston TX,
Sponsor: Epigenetix, Inc.

Sex: All

Age: 18+

Code: NCT05488548

Phase1, Recruiting

A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

for
Solid Tumor, Adult
Location: Seattle WA, San Francisco CA, Duarte CA, San Diego CA,
Sponsor: Corbus Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT06265727

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

for
NSCLC (Advanced Non-small Cell Lung Cancer)
Location: Seattle WA, Edmonton, Sacramento CA, Stanford CA,
Sponsor: BlossomHill Therapeutics

Sex: All

Age: 18+

Code: NCT06706076

Phase1, Phase2, Recruiting

An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 Combined With Ruxolitinib in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Or Post-Essential Thrombocythemia MF (Post ET-MF) Who Have a Suboptimal Response to Ruxolitinib

for
Myelofibrosis
Location: Seattle WA, Duarte CA, Houston TX, Ann Arbor MI,
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT04485260

Phase1, Phase2, Recruiting

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

for
Recurrent Acute Myeloid Leukemia,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT04375631

Phase1, Recruiting

Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease

for
Chronic Graft Versus Host Disease
Location: Seattle WA, New York NY, Boston MA, Tampa FL
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT05996627

Phase2, Recruiting

VENOUS: A Translational Study of Enterococcal Bacteremia

for
Enterococcal Bacteremia
Location: Seattle WA, Houston TX, Detroit MI, Jackson MS,
Sponsor: The University of Texas Health Science Center, Houston

Sex: All

Age: 18+

Code: NCT04410276

Recruiting

Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

for
Angioimmunoblastic T-cell Lymphoma,
Location: Seattle WA, Walla Walla WA, Salt Lake City UT,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT04803201

Phase2, Recruiting

Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations

for
Metastatic Malignant Solid Neoplasm
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT06043713

Phase1, Recruiting

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

for
Chronic Lymphocytic Leukemia, CLL, Mantle Cell Lymphoma, MCL
Location: Seattle WA, Westwood KS, St Louis MO, Fort Wayne IN,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06697184

Phase1, Phase2, Recruiting

Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast Cancer

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: Female

Age: 18+

Code: NCT05874297

Recruiting

A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to Increase Lung Cancer Screening Among Black Community Members, RESTORE Trial

for
Lung Carcinoma
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 50 - 70+

Code: NCT07490860

Recruiting

Exercise for Tumor Suppressive Impact in Men With Prostate Cancer at High-Risk of Progression on Active Surveillance: The REMOVE Trial

for
Prostate Cancer, Prostatic Neoplasms
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: Male

Age: 18+

Code: NCT05918263

Recruiting

The HOPE Biobank Resource (BMT CTN 2402 HOPE)

for
Aplastic Anemias, Hemoglobinopathies, Bone Marrow Failure
Location: Seattle WA, Portland OR, Duarte CA, Milwaukee WI,
Sponsor: Medical College of Wisconsin

Sex: All

Age: 0+

Code: NCT07227155

Recruiting

A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

for
Chronic Graft-versus-host-disease
Location: Seattle WA, Portland OR, Salt Lake City UT,
Sponsor: Syndax Pharmaceuticals

Sex: All

Age: 2+

Code: NCT04710576

Phase2, Recruiting

A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy

for
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Location: Seattle WA, Houston TX, Lexington KY
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07564401

Phase1, Phase2, Recruiting

Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms

for
Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT07094750

Recruiting